DTAB recommends including all antibiotics in the definition of new drug to combat antimicrobial resistance globally.

In a potential advance for melanoma patients, researchers at ChristianaCare's Gene Editing Institute have used CRISPR gene ...

Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...

The horse world has been aware of drug resistance to intestinal parasites for decades, but it has been primarily relegated to ...

Larotrectinib, a novel cancer drug, is making waves in the medical community for its remarkable ability to target a specific ...

The combination of immune checkpoint inhibitors (ICIs) with chemotherapy has revolutionized cancer immunotherapy, significantly improving patient outcomes across various malignancies. ICIs, by ...

H.E. Freddy Svane emphasized the escalating threat of AMR in India during his discussion with ETHealthworld's Rashmi Mabiyan ...

The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics ...

After a roughly 15-year hiatus, a local drug education program is back in Escanaba. School Resource Officer (SRO) Dustin Stempki brought the Drug Abuse Resistance Education (D.A.R.E.) program back to ...

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of ...

His team analyzed literature on miRNA, summarizing the close relationship between these small molecules and cancer. miRNA is a type of non-coding RNA that does not encode proteins, but can target more ...

Union Health Secretary Punya Salila Srivastava highlights India’s production of 50% of the 8 billion global vaccine doses at ...